November Newsmakers

Moustaches fundraise for cancer in 'Movember' movement (WRAL)
Features DCI MoDukes

Lung Cancer and My Carolina Today (WNCN)
Features Jeffrey Clarke, MD.

Dr. Blackwell on Emerging Therapies in TNBC (OncLive)
Features Kimberly Blackwell, MD.

Breast cancer researchers find support from Komen Foundation (The Chronicle)

Learning From Dogs With Cancer (The New York Times)
Features Michael B. Kastan, MD, PhD, executive director, DCI.

Palliative Care explained (UpMatters.com)
Features Arif Kamal, MD.

Study: For many, DCIS treatment unnecessary (Albuquerque Journal)
Features Shelley Hwang, MD.

For Some Thyroid Cancer Patients, Less is More (Duke Forward)
Features Julie Ann Sosa, MD.

Duke Doctor Defends New Breast Cancer Screening Guidelines (TWC News)

Commentary: Debate swirls about screening for prostate cancer (The Chronicle)
Features Steven Patierno, PhD, Deputy Director, DCI.

Older Breast Cancer Patients Still Get Radiation Despite Limited Benefit (HealthCanal)

Patients Split on Discussing Out-of-Pocket Treatment Costs (CureToday.com)
Features S. Yousuf Zafar, MD.

Papers

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
(Journal of the National Cancer Institute)

TNF rs1799964 as a Predictive Factor of Acute Toxicities in Chinese Rectal Cancer Patients Treated With Chemoradiotherapy (Medicine)

One-Carbon Metabolic Factors and Risk of Renal Cell Cancer: A Meta-Analysis (Plos One)

Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma (Plos One)

Awards

Peter Fecci, MD, Phd, Named To The Sontag Foundation's 2015 Distinguished Scientist Award.
Project: "Lost and Found: The Bone Marrow as Counterproductive Site of T Cell Sequestration in GBM"